Omeprazol Genkern (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Genkern, is a proton pump inhibitor presented as a 20 mg tablet for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults and children. GNH USA supplies Omeprazol Genkern as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Omeprazol Genkern as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders: - Gastro‑esophageal reflux disease (GERD): provides symptomatic relief and promotes healing of erosive esophagitis. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumors. - Helicobacter pylori eradication regimens (as adjunct therapy): enhances eradication rates when combined with antibiotics. - NSA‑induced gastropathy prophylaxis: reduces risk of ulcer formation in patients requiring chronic NSAID therapy.

Omeprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually transient and self‑limiting. - Abdominal pain or dyspepsia: occasional discomfort. - Nausea or vomiting: mild gastrointestinal upset. - Flatulence: excess gas production. - Constipation: infrequent bowel habit changes.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis risk. - Acute interstitial nephritis: renal inflammation. - Hypomagnesemia: low serum magnesium with prolonged use. - Vitamin B12 deficiency: reduced absorption over long‑term therapy. - Stevens‑Johnson syndrome/toxic epidermal necrolysis: severe skin reactions. - Fracture risk: possible decrease in bone mineral density with long‑term use.

Omeprazole should be used with consideration of the following precautions: - Assess renal function: dose adjustment may be needed in severe impairment. - Review hepatic status: use with caution in moderate to severe liver disease. - Evaluate for infections: prolonged acid suppression can increase risk of gastrointestinal infections. - Monitor electrolytes: long‑term therapy may affect magnesium and calcium levels. - Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment. - Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Omeprazole may interact with several medicines, altering their effectiveness or safety.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet activity may increase cardiovascular event risk. - Atazanavir and other protease inhibitors: decreased absorption leading to sub‑therapeutic levels. - Methotrexate (high dose): increased serum concentrations and toxicity risk.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR; monitor coagulation parameters. - Digoxin: possible rise in serum levels; observe for toxicity signs. - Diazepam: enhanced sedation; adjust dose if needed. - Iron salts: reduced absorption; separate administration by at least 2 hours.